| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1346602-28-5 | Risperidone EP Impurity E | C24H29FN4O2 |
| 1346602-67-2 | 5,5'-[1,4-Piperazinediylbis[sulfonyl(6-ethoxy-3,1-phenylene)]]bis[1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one] | C38H46N10O8S2 |
| 1346603-25-5 | rel-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride (1:1) | C21H24FN3O4.HCl |
| 1346603-41-5 | N-Nitrosodiethylamine-d4 | C4D4H6N2O |
| 1346603-62-0 | (3S)-9-Fluoro-2,3-dihydro-3-methyl-10-[[2-(methylamino)ethyl]amino]-7-oxo-H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hydrochloride (1:1) | C16H18FN3O4.HCl |
| 1346603-86-8 | 4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinecarboxylic acid 2-(6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)ethyl ester | C24H27FN4O4 |
| 1346604-00-9 | Bisoprolol EP Impurity Q | C16H27NO4 |
| 1346604-13-4 | Allopurinol EP Impurity C | C6H6N6O |
| 1346604-18-9 | Oseltamivir EP Impurity D | C11H13NO4 |
| 1346604-90-7 | Fingolimod-d4 Hydrochloride | C19H29D4NO2.HCl |
| 1346605-26-2 | Hesperitin-d3 | C16H11D3O6 |
| 1346617-30-8 | Escitalopram Desfluoro Analogue | C20H22N2O |
| 1346623-17-3 | Avacopan | C33H35F4N3O2 |
| 1346645-54-2 | 5,12-Dihydro-12,12-dimethylindeno[1,2-c]carbazole | C21H17N |
| 1346669-48-4 | 9-[1,1'-biphenyl]-4-yl-3,3'-bi-9H-carbazole | C36H24N2 |
| 1346674-23-4 | 3,4,7,8-Tetrahydro-7,7-dimethyl-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one | C12H16N2O |
| 1346688-54-7 | 2,6-Dibromo-4-octyl-4H-dithieno[3,2-b:2',3'-d]pyrrole | C16H19Br2NS2 |
| 1346702-53-1 | Methyl 6-bromo-2-(1-methylethyl)-2H-indazole-4-carboxylate | C12H13BrN2O2 |
| 1346704-33-3 | 1-(1-Methylethyl)-N-[(6-methyl-2-oxo-4-propyl-1,2-dihydro-3-pyridinyl)methyl]-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxamide | C31H39N7O2 |
| 1346747-38-3 | Fingolimod-d4 | C19H29D4NO2 |
| 1346747-65-6 | N-Methyl valacyclovir | C14H22N6O4 |
| 1346747-69-0 | N-Ethyl valacyclovir | C15H24N6O4 |
| 1346792-67-3 | 9-[3-(9H-Carbazol-9-yl)phenyl]-3-[4-(1-phenyl-1H-benzimidazol-2-yl)phenyl]-9H-carbazole | C49H32N4 |
| 1346808-41-0 | 5-Methylisoxazole-4-boronic acid pinacol ester | C10H16BNO3 |
| 1346809-61-7 | 3-bromo-5H-pyrrolo[3,4-b]pyridin-7(6H)-one | C7H5BrN2O |
| 1346918-32-8 | Tirofiban impurity 12 | C13H19NO5S |
| 1346948-93-3 | 5-Bromo-4-cyclopropyl-1H-1,2,3-triazole | C5H6BrN3 |
| 1347001-80-2 | 2-[[6-[(3R)-3-Aamino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile compd. with benzenemethanol (1:1) | C18H21N5O2.C7H8O |
| 1347304-18-0 | N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]sulfinyl]benzamide | C22H18N4O2S |
| 1347736-74-6 | 4,7-Dibromo-5-fluoro-2,1,3-benzothiadiazole | C6HBr2FN2S |
| 1347747-71-0 | 4-[(Methylsulfonyl)oxy]piperidine | C6H13NO3S |
| 1347750-75-7 | 5,8,11-Trioxa-2-azatetradecanedioic acid 1-(1,1-dimethylethyl) ester | C14H27NO7 |
| 1347758-80-8 | N-[1,1'-Biphenyl]-4-yl-9,9-dimethyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-9H-fluoren-2-amine | C39H38BNO2 |
| 1348536-59-3 | N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]sulfonyl]benzamide | C22H18N4O3S |
| 1348664-75-4 | alpha-(2-Fluorophenyl)-alpha-(1H-1,2,4-triazol-1-ylmethyl)-1H-1,2,4-triazole-1-ethanol | C13H13FN6O |
| 1349151-98-9 | 1-Isopropyl-6-oxo-1,6-dihydropyridine-3-boronic acid pinacol ester | C14H22BNO3 |
| 1349171-28-3 | 2-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyridine | C17H20BNO2 |
| 1349500-09-9 | N-[[2-[[[4-[[[(Heptyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester | C35H43N7O5 |
| 1349708-91-3 | 4-Bromo-5-chloro-2-fluorobenzoic acid | C7H3BrClFO2 |
| 1349715-55-4 | 4-Bromo-5-fluoro-2-methylbenzoic acid | C8H6BrFO2 |
| 1349715-77-0 | [(2-Fluorophenyl)methyl]hydrazine hydrochloride (1:2) | C7H9FN2.2(HCl) |
| 1349718-54-2 | 3,4-Dichloro-2-fluorobenzaldehyde | C7H3Cl2FO |
| 1349718-98-4 | 2,4-Dichloro-6-fluorobenzonitrile | C7H2Cl2FN |
| 1349723-93-8 | Elacestrant dihydrochloride | C30H38N2O2 .2ClH |
| 1349796-36-6 | N-[4-[[[3-[(3,5-Dimethoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-3-methoxy-4-methylbenzamide | C31H29N5O6S |
| 1349901-36-5 | 9-[8-(Diphenylphosphinyl)-2-dibenzofuranyl]-9H-carbazole | C36H24NO2P |
| 1349904-82-0 | Taccalonolide AJ | C34H44O14 |
| 1350206-14-2 | 6'-Methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine | C18H16N2O2S |
| 1350288-77-5 | Rivaroxaban Impurity 60 | C19H18ClN3O5S |
| 1350323-88-4 | 5-Methoxy-1-methyl-1H-pyrazole | C5H8N2O |